Troleandomycin

醋竹桃霉素

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameTroleandomycin
Drug Alias Nametroleandomycinum三乙酰竹桃霉素troleandomicina竹桃霉素三乙酸酯Triocetin +[8] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1969/05/27
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeJ01FA08
Related LinksWikipediaDrugBankKEGG